Aclarion, Inc. (ACON) Stock

Healthcare · Health Information Services · Member of Other US Stocks

Aclarion, Inc. (ACON) closed at USD 1.94 on 2026-10-14, a change of -74.8 % over the past year, with a market capitalization of USD 5.63M.

Aclarion, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Aclarion, Inc. key figures

Previous close

USD 1.94 (2026-10-14)

1-year change

-74.8 %

Market cap

USD 5.63M

Enterprise value

USD -10.67M

P/E ratio (trailing)

-0.29

P/E ratio (forward)

-0.36

EPS (trailing)

-6.74

EPS (forward)

-5.47

PEG ratio

n/a

Price to book

0.28

Revenue growth

30.5 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.96

Employees

10

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Aclarion, Inc.

Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Aclarion, Inc. and compare it with other stocks.